(Q43842999)

27 November 2017

title

The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid (English)

1 reference

27 November 2017

author name string

Elisabetta Miserocchi

1

1 reference

27 November 2017

Stefanos Baltatzis

2

1 reference

27 November 2017

Manolette R Roque

3

1 reference

27 November 2017

A Razzaque Ahmed

4

1 reference

27 November 2017

C Stephen Foster

5

1 reference

27 November 2017

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

109

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

111-118

1 reference

Ocular cicatricial pemphigoid

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Progression of disease in ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunologic Aspects of Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Antibodies against conjunctival basement membrane zone. Occurrence in cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

The Acute Manifestations of Ocular Cicatricial Pemphigoid: Diagnosis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Systemic chemotherapy for ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive and cytotoxic drugs in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Azathioprine in the treatment of muco-cutaneous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive therapy for progressive ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Remission and Recurrence after Withdrawal of Therapy for Ocular Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Bullous Pemphigoid Responding to Sulfapyridine and the Sulfones

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Sulfones and sulfonamides in dermatology today

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive drugs in immune and inflammatory ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive Therapy for Severe Chronic Uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

The complications of systemic corticosteroid therapy in the elderly. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

Immunosuppressive therapy for external ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900863-6

7 January 2021

10.1016/S0161-6420(01)00863-6

Identifiers

DOI

1 reference

27 November 2017

1 reference